Subscribe To
Cpz: a unique long/short fund for tactical investors
Calamos Long/Short Equity & Dynamic Income Trust is a more defensive fund that takes both long and short positions and incorporates fixed-income expos...
September 10, 2023, 8:22 am
Nvidia's failed attempt to acquire this semiconductor powerhouse could lead to the biggest ipo of 2023
Nvidia's attempt to buy Arm Holdings several years ago was eventually scuttled by regulators. Arm's cen...
September 10, 2023, 8:05 am
Spotting the sweet spot: when to dive into tsla stock for maximum gains
For the long term, I like the growth prospects of electric vehicle (EV) manufacturer Tesla (NASDAQ: TSLA ). However, financial traders need to time t...
September 10, 2023, 7:56 am
Is docusign stock finally on the road to recovery after its spectacular fall from grace?
DocuSign delivered a beat and raise quarter, but growth remains anemic. The company is making progress but has yet to capitalize on its contract lifec...
September 10, 2023, 7:17 am
1 top growth stock transforming into an ai software platform
MongoDB reported a 40% jump in revenue last quarter, but that growth rate will slow dramatically going ...
September 10, 2023, 7:09 am
In a historic first, rocket lab reuses a rocket engine
In August, Rocket Lab successfully launched a rocket equipped with eight new engines and one reused one...
September 10, 2023, 7:07 am
Investors may not have seen the best from eli lilly stock yet. here's why.
Eli Lilly's type 2 diabetes treatment, called Mounjaro, is helping fuel new growth for the company. In ...
September 10, 2023, 6:12 am
Gold prices remain under pressure amid strong us economic data; focus now on cpi data this week
The Federal Reserve expressed concerns that this robust economic activity could lead to continued inflationary pressures, potentia...
September 10, 2023, 5:44 am
Allist and arrivent announce interim results from ongoing phase 1b trial with furmonertinib at the 2023 world conference on lung cancer
SHANGHAI, China, Sept. 10, 2023 (GLOBE NEWSWIRE) — Allist Pharmaceuticals Co., Ltd. (“Allist”) and ArriVent Biopharma, Inc. (“ArriVent”) tog...
September 10, 2023, 5:30 am
Dyne therapeutics: muscle disease oligo therapy developer in early stages
Dyne Therapeutics is developing treatments for genetically driven muscle diseases, focusing on Myotonic...
September 10, 2023, 5:25 am
Cathie wood says artificial intelligence (ai) software may be a $14 trillion market: 2 superb growth stocks to buy now and hold through the boom
Ark Invest says AI software revenue could increase by 42% annually to reach $14 trillion by 2030. Sales...
September 10, 2023, 5:15 am
Gold and silver prices on september 10: check latest rates in your city
Factors such as global gold demand, currency values in various nations, prevailing interest rates, and government regulations related to gold trade al...
September 10, 2023, 4:59 am
Eog resources offers value others can't
EOG Resources stands out among its competitors in the Permian basin due to its unique approach to cash management and resource optimization. The compa...
September 10, 2023, 4:29 am
Analysis: wegovy launch in uk may underline novo's need to get ahead of lilly
Novo Nordisk's decision to launch its weight-loss drug Wegovy in Britain last week despite severe supply constraints may partly have been motivated by...
September 10, 2023, 3:07 am
Better high yield buy: enterprise products partners or energy transfer?
Energy Transfer and Enterprise Products Partners are popular midstream stocks with attractive and well-covered distributions. We have traditiona...
September 10, 2023, 2:48 am
Eli lilly: unusual demand is sending the stock higher
Eli Lilly and Co. (lly) shares have soared, ra...
September 9, 2023, 8:40 pm
Recession outlook, ai technology, a potential government shutdown: goldman sachs tech conference
Yahoo Finance Executive Editor Brian Sozzi interviewed leaders in finance and government about the economy, the outlook for a recession, AI, remote wo...
September 9, 2023, 8:25 pm
Usd/jpy weekly outlook
USD/JPY’s near term rally resumed last week but retreated after edging higher to 147.88. Initial bias...
September 9, 2023, 2:46 pm
Usd/chf weekly outlook
USD/CHF’s rebound from 0.8551 resumed last week and hit as high as 0.8943. But as a temporary top was then formed, initial bias stays neutral this w...
September 9, 2023, 2:31 pm
Usd/cad weekly outlook
USD/CAD’s rally from 1.3091 resumed last week but retreated after hitting 1.3693. Initial bias remain...
September 9, 2023, 2:21 pm